MetfOrmin BenefIts Lower Extremities With Intermittent Claudication
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.
Also called NCT05132439
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 200 participants
- Registry
-
NCT05132439
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT05132439. Randomized; quadruple masking; primary purpose treatment. Start 2022-03-01 (actual); primary completion 2027-02-28 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- MetfOrmin BenefIts Lower Extremities With Intermittent Claudication
- Acronym
- MOBILE IC
- Condition
- Intermittent Claudication
- Intervention (Drug)
- Metformin ER
- Intervention (Drug)
- placebo
- Lead sponsor
- VA Office of Research and Development
- Collaborator
- University of Pittsburgh
- Collaborator
- Northwestern University
- Collaborator
- San Francisco Veterans Affairs Medical Center
Record details
- Record id
cardio:ct-nct05132439- Content hash
eabbe38775b79fe5035e7776c67f6e702ab654032dc0b6277019fb91b542d047